Loading, Please Wait...
SAN FRANCISCO, CA--(Marketwired - Feb 25, 2016) - The cystic fibrosis market had a market value of more than USD 695 million in 2012 and is anticipated to rise drastically over the future period in the major 8 developed countries and will surpass USD 4.0 billion by 2019. Thus associates to a compounded annual growth rate of more than 30%.
Original treatment with disease-modifying mechanism of action is the main feature increasing the growth of the market in terms of value. The constructive effect of the market's new applicant will counteract the effects of major patent failures throughout the estimated period.
Browse Full Research Report With TOC On "Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 - CFTR Modulators Initiate Drive towards Personalized Treatment and Market Growth" at: http://www.radiantinsights.com/research/cystic-fibrosis-therapeutics-in-major-developed-markets-to-2019-cftr-modulators-initiate-drive-towards-personalized-treatment-and-market-growth
The first ever cystic fibrosis therapy was CFTR (Cystic Fibrosis Transmembrane conductance Regulator) for treating the root reasons of the illness instead of the symptom. This resulted into the Patients' enhanced help and value of life. Among CFTR modulator, Kalydeco was the first one to reach the market. This was in the market since 2012. It could treat only a tiny part of CF people, yet the market value had a major effect on it.
With the market entry of Ataluren & lumacaftor, the effect is going to be repetitive to a huge extent, because of the ability of it being used on a bigger number of the CF sufferers. Llumacaftor, Kalydeco, and early previous phase CFTR modulator are developed by Vertex Pharmaceuticals Inc. These are hence anticipated to be performing a major role in developing the forthcoming market.
Browse related reports by Radiant Insights:
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets.